Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Glioma
100%
Glioblastoma
88%
Clear Cell Renal Cell Carcinoma (ccRCC)
77%
Tumor
76%
Genome-wide Association Study
71%
Confidence Interval
62%
Glioma Risk
52%
Patient-derived Xenograft
47%
Odds Ratio
45%
Population-based Study
40%
Molecular Subtypes
35%
Gram-negative Bloodstream Infections
32%
Renal Cell Carcinoma
28%
Germline Variants
28%
Isocitrate Dehydrogenase 1 (IDH1)
26%
IDH mutation
24%
Incidence Rate
24%
Temozolomide
23%
Statistical Analysis
22%
Gene Expression
21%
Single nucleotide Polymorphism
21%
Mendelian Randomization
21%
Mayo Clinic
20%
Risk Loci
20%
Necrosis
20%
Bloodstream Infection
18%
Risk Factors
18%
Hazard Ratio
18%
Tumefactive Demyelination
18%
IDH-mutant Glioma
17%
Cancer Genome Atlas
17%
Copy number Variation
17%
Overall Survival
17%
Low-grade Glioma
16%
Size Grading
16%
SNP
16%
Etiology
16%
Low Risk
16%
Obesity
16%
BRCA1-associated Protein 1 (BAP1)
15%
Metastatic Renal Cell Carcinoma (mRCC)
15%
Minnesota
15%
Xenograft
15%
Olmsted County
15%
Blood-brain Barrier
14%
Bacteremia
13%
Formalin-fixed Paraffin-embedded Tissue
13%
Metastatic Tumor
13%
Chronic Lymphocytic Leukemia
13%
Antibody-drug Conjugate
13%
Medicine and Dentistry
Neoplasm
84%
Clear Cell Renal Cell Carcinoma
83%
Ganglioglioma
63%
Glioblastoma
56%
Xenograft
38%
Bloodstream Infection
37%
Temozolomide
26%
Demyelination
22%
Metastatic Carcinoma
21%
Mendelian Randomization Analysis
20%
Overall Survival
20%
Necrosis
18%
Odds Ratio
18%
Biological Marker
18%
Isocitrate Dehydrogenase
16%
The Cancer Genome Atlas
15%
Clear Cell
15%
Diseases
14%
Hazard Ratio
14%
Promoter Region
14%
Multiple Sclerosis
13%
Progression Free Survival
11%
Gene Expression Profiling
11%
Malignant Neoplasm
10%
Transcriptome
10%
Proportional Hazards Model
10%
Intracranial Tumor
10%
In Vitro
10%
Oligoastrocytoma
10%
Blood Brain Barrier
9%
Radiation Therapy
9%
Primary Tumor
9%
Tumour Heterogeneity
9%
B-Cell Chronic Lymphocytic Leukemia
9%
Germ Cell
7%
Magnetic Resonance Imaging
7%
Protein Expression
7%
DNA Methylation
7%
Gene Expression
7%
Breast Tumor
7%
Breast Cancer
6%
Neuro-Oncology
6%
Genome Wide Association Study
6%
Patient Referral
6%
Upregulation
6%
Tumor Progression
6%
Antibiotic Resistance
6%
Cohort Effect
6%
Pharmacodynamics
6%
Protein MDM2
6%
Biochemistry, Genetics and Molecular Biology
Genome-Wide Association Study
65%
Genomics
34%
Germline
33%
Germ Cell
33%
Gene Expression
29%
Genetics
28%
RNA
26%
Gene Expression Profiling
24%
Isocitrate Dehydrogenase
24%
Single Nucleotide Polymorphism
24%
Overall Survival
23%
Single-Nucleotide Polymorphism
18%
Allele
18%
Protein Expression
18%
Polygenic Score
18%
Transcriptome
17%
Mass Spectrometry
17%
Wild Type
15%
Promoter Region
15%
Methylation
15%
IDH1
15%
Cyclin Dependent Kinase Inhibitor 2A
14%
Exome Sequencing
14%
Copy-Number Variation
14%
Subtyping
13%
Radiosensitization
13%
Candidate Gene
12%
Clinical Trial
12%
Expression Analysis
12%
Proteomics
12%
RNA Sequencing
11%
DNA Methylation
11%
Cancer Cell
10%
BRCA1
10%
BAP1
10%
PBRM1
10%
P53
10%
MicroRNA
10%
Telomere Length
10%
Messenger RNA
9%
RNA Degradation
9%
C-Terminus
9%
Array Comparative Genomic Hybridization
9%
Proteome
9%
Body Mass
8%
Dose Response
8%
Epidermal Growth Factor Receptor
8%
Differentially Expressed Gene
8%
Progression Free Survival
8%
Transcription Factors
8%